Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2013 7
2014 9
2015 7
2016 2
2017 1
2018 1
2020 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Anticancer agent α-sulfoquinovosyl-acylpropanediol enhances the radiosensitivity of human malignant mesothelioma in nude mouse models.
Inamasu E, Tsuchiya T, Yamauchi M, Nishi K, Matsuda K, Sugawara F, Sakaguchi K, Mori R, Matsumoto K, Miyazaki T, Hatachi G, Doi R, Watanabe H, Tomoshige K, Matsuda N, Higami Y, Shimokawa I, Nakashima M, Nagayasu T. Inamasu E, et al. J Radiat Res. 2022 Jan 20;63(1):19-29. doi: 10.1093/jrr/rrab090. J Radiat Res. 2022. PMID: 34738103 Free PMC article.
Study protocol for efficacy and safety of steroid-containing mouthwash to prevent chemotherapy-induced stomatitis in women with breast cancer: a multicentre, open-label, randomised phase 2 study.
Kuba S, Yamanouchi K, Matsumoto M, Maeda S, Hatachi T, Sakiko S, Kawashita Y, Morita M, Sakimura C, Inamasu E, Shibata K, Otsubo R, Yano H, Nose S, Miyamoto J, Sato S, Kanetaka K, Taniguchi H, Umeda M, Nagayasu T, Eguchi S. Kuba S, et al. Among authors: inamasu e. BMJ Open. 2020 Feb 13;10(2):e033446. doi: 10.1136/bmjopen-2019-033446. BMJ Open. 2020. PMID: 32060155 Free PMC article. Clinical Trial.
The Efficacy of Software to Help Patients Understand Drug for Adjuvant Treatment for Breast Cancer: A Pilot Randomized Controlled Trial.
Kuba S, Yamanouchi K, Morita M, Sakimura C, Inamasu E, Hatachi T, Otsubo R, Matsumoto M, Yano H, Miyamoto J, Sato S, Nakagawa H, Kanetaka K, Takatsuki M, Nagayasu T, Eguchi S. Kuba S, et al. Among authors: inamasu e. Acta Med Okayama. 2020 Apr;74(2):95-101. doi: 10.18926/AMO/58266. Acta Med Okayama. 2020. PMID: 32341582 Free article. Clinical Trial.
Dramatic response to crizotinib in an ALK-positive adenocarcinoma patient with disseminated intravascular coagulation.
Toyokawa G, Takenoyama M, Watanabe S, Toyozawa R, Inamasu E, Kojo M, Shiraishi Y, Morodomi Y, Takenaka T, Hirai F, Yamaguchi M, Taguchi K, Seto T, Ichinose Y. Toyokawa G, et al. Among authors: inamasu e. J Thorac Oncol. 2013 Nov;8(11):e96-8. doi: 10.1097/JTO.0b013e3182a008ed. J Thorac Oncol. 2013. PMID: 24128725 Free article. No abstract available.
25 results